Published in J Clin Microbiol on July 01, 1998
Updated review of blood culture contamination. Clin Microbiol Rev (2006) 3.16
Blood culture contamination: persisting problems and partial progress. J Clin Microbiol (2003) 2.62
Multiplex PCR protocol for the diagnosis of staphylococcal infection. J Clin Microbiol (2001) 2.08
Simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci in positive blood cultures by real-time PCR with two fluorescence resonance energy transfer probe sets. J Clin Microbiol (2004) 1.63
Correlation between genotype and phenotypic categorization of staphylococci based on methicillin susceptibility and resistance. J Clin Microbiol (2001) 1.54
Species-level identification of staphylococcal isolates by real-time PCR and melt curve analysis. J Clin Microbiol (2005) 1.36
Comparison of the MicroScan, VITEK 2, and Crystal GP with 16S rRNA sequencing and MicroSeq 500 v2.0 analysis for coagulase-negative Staphylococci. BMC Microbiol (2008) 1.34
Rapid identification of staphylococcal strains from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis. J Clin Microbiol (2005) 1.33
Blood culture contamination in Tanzania, Malawi, and the United States: a microbiological tale of three cities. J Clin Microbiol (2006) 1.12
Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin. Antimicrob Agents Chemother (1999) 1.00
Emerging technologies for rapid identification of bloodstream pathogens. Clin Infect Dis (2014) 0.98
Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol (2008) 0.93
Resident bacterial flora in the skin of C57BL/6 mice housed under SPF conditions. J Am Assoc Lab Anim Sci (2010) 0.89
Simplified and reliable scheme for species-level identification of Staphylococcus clinical isolates. J Clin Microbiol (2007) 0.87
Staph ID/R: a rapid method for determining staphylococcus species identity and detecting the mecA gene directly from positive blood culture. J Clin Microbiol (2011) 0.86
Multicenter evaluation of a modified protocol for the RAPIDEC staph system for direct identification of Staphylococcus aureus in blood cultures. J Clin Microbiol (1998) 0.86
Multilocus sequence typing and further genetic characterization of the enigmatic pathogen, Staphylococcus hominis. PLoS One (2013) 0.84
Antibiotic resistance in sepsis patients: evaluation and recommendation of antibiotic use. N Am J Med Sci (2013) 0.80
Whole-Genome Sequence of Staphylococcus hominis Strain J31 Isolated from Healthy Human Skin. Genome Announc (2017) 0.75
Comparison of methods for the identification of microorganisms isolated from blood cultures. Ann Clin Microbiol Antimicrob (2016) 0.75
Acute gastrointestinal dilation in laboratory rhesus monkeys in the Korea National Primate Research Center. Lab Anim Res (2012) 0.75
L. Barth Reller, M.D. J Clin Microbiol (2012) 0.75
Validation of the MicroScan-96 for the species identification and methicillin susceptibility testing of clinical significant coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis (2011) 0.75
Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol (1975) 16.73
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis (1983) 10.03
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis (1997) 9.39
Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med (1991) 9.11
Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev (1994) 5.77
Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med (1989) 4.23
Update on detection of bacteremia and fungemia. Clin Microbiol Rev (1997) 4.01
Rapid and economical method for species identification of clinically significant coagulase-negative staphylococci. J Clin Microbiol (1995) 2.43
Evaluation of two commercial systems for identification of coagulase-negative staphylococci to species level. Diagn Microbiol Infect Dis (1994) 1.71
Identification of Staphylococcus species and subspecies with the MicroScan Pos ID and Rapid Pos ID panel systems. J Clin Microbiol (1991) 1.69
Doing it right the first time: quality improvement and the contaminant blood culture. J Clin Microbiol (1997) 1.63
Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus species. Diagn Microbiol Infect Dis (1994) 1.49
Staphylococcus hominis subsp. novobiosepticus subsp. nov., a novel trehalose- and N-acetyl-D-glucosamine-negative, novobiocin- and multiple-antibiotic-resistant subspecies isolated from human blood cultures. Int J Syst Bacteriol (1998) 1.31
Evaluation of MicroScan Rapid Pos Combo panels for identification of staphylococci. J Clin Microbiol (1992) 1.15
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis (1983) 10.03
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis (1997) 9.39
Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol (1981) 8.49
Campylobacter enteritis. N Engl J Med (1981) 7.98
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia. J Clin Microbiol (1982) 6.19
Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. J Clin Microbiol (1992) 5.09
Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. Lancet (1999) 4.64
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis (1983) 4.52
Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49
BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol (1990) 4.35
Serology of coccidioidomycosis. Clin Microbiol Rev (1990) 4.18
Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis (1977) 4.00
Controlled evaluation of BacT/Alert standard aerobic and FAN aerobic blood culture bottles for detection of bacteremia and fungemia. J Clin Microbiol (1995) 3.51
Evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1973) 3.44
Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis (1977) 3.15
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin Infect Dis (1998) 2.81
Comparison of acridine orange and Gram stains for detection of microorganisms in cerebrospinal fluid and other clinical specimens. J Clin Microbiol (1981) 2.77
Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol (1994) 2.77
Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles. J Clin Microbiol (1991) 2.62
Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia. J Clin Microbiol (1997) 2.54
Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. J Clin Microbiol (1993) 2.49
Bactericidal antibody after colonization with Neisseria meningitidis. J Infect Dis (1973) 2.35
Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol (1994) 2.32
Comparison of acridine orange, methylene blue, and Gram stains for blood cultures. J Clin Microbiol (1982) 2.30
A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. J Infect Dis (2000) 2.29
Effect of agitation and terminal subcultures on yield and speed of detection of the Oxoid Signal blood culture system versus the BACTEC radiometric system. J Clin Microbiol (1989) 2.25
Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates. J Antimicrob Chemother (1982) 2.25
Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J Clin Microbiol (2001) 2.23
Controlled evaluation of BacT/alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteremia and fungemia. J Clin Microbiol (1995) 2.21
Clinical microbiology in developing countries. Emerg Infect Dis (2001) 2.18
Clinical impact of bacteria and fungi recovered only from broth cultures. J Clin Microbiol (1995) 2.17
Diagnostic utility of postmortem blood cultures. Arch Pathol Lab Med (1993) 2.06
Evaluation of transport and storage techniques for isolation of Campylobacter fetus subsp. jejuni from turkey cecal specimens. J Clin Microbiol (1981) 2.06
Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04
Application of rejection criteria for stool ovum and parasite examinations. J Clin Microbiol (1992) 2.04
Evaluation of preservative fluid for urine collected for culture. J Clin Microbiol (1979) 2.03
Birthweights and growth of infants in five Aboriginal communities. Aust N Z J Public Health (2000) 2.01
Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1986) 1.98
Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb Drug Resist (2004) 1.97
Use of a sodium polyanetholesulfonate disk for the identification of Gardnerella vaginalis. J Clin Microbiol (1985) 1.97
Ubiquitous presence of a mecA homologue in natural isolates of Staphylococcus sciuri. Microb Drug Resist (1996) 1.95
Reliability of cord formation in BACTEC media for presumptive identification of mycobacteria. J Clin Microbiol (1993) 1.94
Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles. J Clin Microbiol (1992) 1.92
Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med (1985) 1.92
Rejection criteria for endotracheal aspirates from adults. J Clin Microbiol (1993) 1.91
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother (1982) 1.89
Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. Diagn Microbiol Infect Dis (1993) 1.83
Controlled comparison of original vented aerobic fan medium with new nonvented BacT/ALERT FA medium for culturing blood. J Clin Microbiol (2001) 1.81
Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth. J Clin Microbiol (1982) 1.81
Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med (1983) 1.79
Rationale for selective use of anaerobic blood cultures. J Clin Microbiol (1993) 1.77
Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. J Infect Dis (1982) 1.74
Enriched brucella medium for storage and transport of cultures of Campylobacter fetus subsp. jejuni. J Clin Microbiol (1980) 1.73
Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe. J Infect Dis (1988) 1.72
Microtiter method for MIC testing with spherule-endospore-phase Coccidioides immitis. J Clin Microbiol (1988) 1.72
Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet (1982) 1.68
Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67
Cryptosporidium, enterocytozoon, and cyclospora infections in pediatric and adult patients with diarrhea in Tanzania. Clin Infect Dis (1999) 1.64
Bacterial endocarditis caused by Oerskovia turbata. Ann Intern Med (1975) 1.61
Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J Clin Microbiol (2005) 1.60
Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalized patients >/=15 years old, Bangkok. J Infect Dis (1999) 1.60
Duration of incubation of fungal cultures. J Clin Microbiol (1996) 1.60
Controlled evaluation of supplemented peptone and Bactec blood culture broths for the detection of bacteremia and fungemia. J Clin Microbiol (1985) 1.58
Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob Agents Chemother (2001) 1.58
Seasonal variation in the etiology of bloodstream infections in a febrile inpatient population in a developing country. Int J Infect Dis (2001) 1.56
Comparative evaluation of Oxoid Signal and BACTEC radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1988) 1.55
Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob Agents Chemother (1990) 1.54
Comparison of direct and standard antimicrobial disk susceptibility testing for bacteria isolated from blood. J Clin Microbiol (1979) 1.54
Gardnerella vaginalis bacteremia: a review of thirty cases. Obstet Gynecol (1984) 1.53
A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3-kinase. FEBS Lett (1994) 1.50
Comparison of immunoblot analyses of spherule-endospore-phase extracellular protein and mycelial-phase antigen of Coccidioides immitis. Infect Immun (1986) 1.47
Relevance of the number of positive bottles in determining clinical significance of coagulase-negative staphylococci in blood cultures. J Clin Microbiol (2001) 1.45
Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Res Microbiol (1989) 1.43